Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium.
Journal: JCO oncology practice
Published: December 04, 2025
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2.
Journal: Cancer research communications
Published: December 16, 2024
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies.
Journal: Targeted oncology
Published: November 27, 2024
Baseline weight recovery and mortality risk in head and neck cancer.
Journal: Head & neck
Published: April 21, 2024
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
Journal: JCO precision oncology
Published: April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
Journal: JCO precision oncology
Published: April 11, 2024
Low booster uptake in cancer patients despite health benefits.
Journal: medRxiv : the preprint server for health sciences
Published: November 14, 2023
Low booster uptake in cancer patients despite health benefits.
Journal: iScience
Published: October 30, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Journal: Targeted oncology
Published: March 27, 2023
Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system.
Journal: Head & neck
Published: March 11, 2023
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Journal: Investigational new drugs
Published: December 07, 2022
Last Updated: 09/26/2026